Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0.522. It has been cited 12 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.137
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NCI NIH HHS
Grant: F30 CA221004
NCI NIH HHS
Grant: R01 CA188571
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
National Institutes of Health
Grant: 5F30CA221004-03
Mechanisms of B-Myb oncogenicity in ovarian cancer
National Institutes of Health
Grant: 3R01CA188571-05S1
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
FWCI
1.84
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals